UBI company Inficure in new global collaboration agreement with biotech giant CSL
Inficure Bio has signed a contract for global collaboration through which CSL will use Inficure’s N-IF test model.
Inficure Bio has signed a contract for global collaboration through which CSL will use Inficure’s N-IF test model.
Inficure Bio AB tar för första gången i företagets historia in externt riskkapital. Valet föll på lokal kompetens och finansiering – och målet är att inom ett år etablera sig på den internationella marknaden för utveckling av läkemedel mot inflammation och fibros.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.